Genmab A/S (GMAB)

Genmab Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	1,204	1,326	817	999.61	599.17
Depreciation & Amortization	103	77	43	52.1	-
Stock-Based Compensation	128	105	85	63.19	-
Other Adjustments	-14	-223	83	-59.16	-117.6
Change in Receivables	-166	-230	116	-305.57	-
Changes in Inventories	-9	-1	-8	-	-
Changes in Accounts Payable	400	122	90	40.73	-
Changes in Income Taxes Payable	-460	-50	-155	-227.85	-113.47
Changes in Other Operating Activities	-	-	-	-	-27.37
Operating Cash Flow	1,186	1,126	1,071	563.06	340.72
Operating Cash Flow Growth	5.33%	5.13%	90.21%	65.26%	-67.73%
Capital Expenditures	-37	-27	-53	-45.63	-38.54
Purchases of Intangible Assets	-18	-17	-1	-	-
Purchases of Investments	-995	-1,256	-1,582	-1,396	-2,388
Proceeds from Sale of Investments	2,622	1,636	1,451	1,044	2,280
Payments for Business Acquisitions	-7,215	-1,783	-	-	-
Investing Cash Flow	-5,643	-1,447	-185	-397.4	-146.96
Long-Term Debt Issued	5,500	-	-	-	-
Net Long-Term Debt Issued (Repaid)	5,500	-	-	-	-
Issuance of Common Stock	23	19	21	40.3	20.65
Repurchase of Common Stock	-430	-560	-81	-130.69	-68.36
Net Common Stock Issued (Repurchased)	-407	-541	-60	-90.39	-47.71
Other Financing Activities	-304	-25	-29	-23.17	-16.52
Financing Cash Flow	4,789	-566	-89	-113.56	-64.23
Effect of Exchange Rate Changes on Cash and Cash Equivalents	3	63	-12	82.62	129.99
Net Cash Flow	332	-887	797	52.1	129.53

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q